🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-03
Trial ID
NCT00446862
The study will evaluate the safety and efficacy of Replagal® (agalsidase al...
Status
No Longer Available
Location
AKDHC Tucson Campbell
Start Date
TBD
Trial ID
NCT01031173
Treatments Being Tested
The goal of this observational study is to learn how enzyme replacement the...
Status
Enrolling By Invitation
Location
#13
Start Date
2025-03-24
Trial ID
NCT06880250
People with Fabry disease have an alteration in their genetic material (DNA...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2001-02
Trial ID
NCT00074984
Treatments Being Tested
People with Fabry disease have an alteration in their genetic material (DNA...
Status
Withdrawn
Location
Trident Nephrology Associates
Start Date
2006-04
Trial ID
NCT00312767
Treatments Being Tested
The aim of this study was to investigate renal function decline by measured...
Status
Completed
Location
National University Hospital, Department of Medical Endocrinology
Start Date
2015-04
Trial ID
NCT02969200
Treatments Being Tested
This is an exploratory study to evaluate changes in glycosphingolipid level...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01650779
Treatments Being Tested
People with Fabry Disease have an alteration in their genetic material (DNA...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-01
Trial ID
NCT00081497
Treatments Being Tested
This study was designed to determine appropriate treatment with Fabrazyme a...
Status
Terminated
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00837824
Treatments Being Tested
Primary Objective: To assess reduction of plasma lyso-GL3 level after swit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09
Trial ID
NCT04143958
Treatments Being Tested